RFA
XBI icon

Register Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Register Financial Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Buy
1,695
+155
+10% +$21K 0.08% 206
2026
Q1 		$197K Buy
1,540
+160
+12% +$20K 0.07% 216
2025
Q4 		$168K Buy
1,380
+328
+31% +$37.6K 0.07% 213
2025
Q3 		$105K Hold
1,052
– – 0.04% 237
2025
Q2 		$87.2K Hold
1,052
– – 0.04% 243
2025
Q1 		$85.3K Hold
1,052
– – 0.04% 222
2024
Q4 		$94.7K Hold
1,052
– – 0.05% 215
2024
Q3 		$104K Hold
1,052
– – 0.05% 211
2024
Q2 		$97.5K Hold
1,052
– – 0.05% 268
2024
Q1 		$99.8K Buy
1,052
+7
+0.7% +$650 0.05% 258
2023
Q4 		$93.3K Buy
+1,045
New +$77.6K 0.06% 192

Other funds holding XBI

MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
RAM
Riggs Asset Management Dallas, Pennsylvania $560M AUM 64.94% 1-Year Est. Return

Register Financial Advisors's XBI Position: Q2 2026 in Review

Register Financial Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 10% in Q2 2026, buying an estimated $21K and bringing the position to 1,695 shares worth $268K. The position accounts for 0.08% of the portfolio, ranked #206.

Register Financial Advisors first reported a position in XBI in Q4 2023 and has held it in 11 quarters since. 393 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Register Financial Advisors held 1,695 shares of State Street SPDR S&P Biotech ETF worth $268K as of Q2 2026.
  • Register Financial Advisors bought 155 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $21K.
  • State Street SPDR S&P Biotech ETF made up 0.08% of Register Financial Advisors's portfolio in Q2 2026, its #206 holding.
  • Register Financial Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 11 quarters since.
  • 393 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Register Financial Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.